Human F2R (Proteinase-activated receptor 1) ELISA Kit EH1062 from Fine Biotech Co., Ltd. | Biocompare.com

Supplier Images

Human F2R(Proteinase-activated receptor 1) ELISA Kit

Human F2R(Proteinase-activated receptor 1) ELISA Kit

Be the first to write a review!

Citations:

Supplier Page from
Fine Biotech Co., Ltd. for
Human F2R (Proteinase-activated receptor 1) ELISA Kit

Product Specs
ItemHuman F2R (Proteinase-activated receptor 1) ELISA Kit
CompanyFine Biotech Co., Ltd.
Price $400.00Supplier Page View Company Product Page
Catalog NumberEH1062
Quantity96T
ApplicationsELISA
Detection Range0.156-10ng/ml
DetectionSandwich ELISA, Double Antibody
PrecisionIntra-Assay: CV<8%, Inter-Assay: CV<10%
ReactivityHuman
Sample TypeSerum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
Sensitivity0.094ng/ml
Detection TargetF2R
NCBI Full Gene Namecoagulation factor II thrombin receptor
NCBI Gene AliasesCF2R, HTR, PAR-1, PAR1, TR
Research AreaNeuroscience, Cardiovascular, Epigenetics, Signal Transduction, Metabolism
Assay Time4 hours

Add to Compare List

Fine Biotech Co., Ltd.

Fine Biotech Co., Ltd.

1-2 Floor, BLD 22, Optics Valley Biopharmaceutical Accelerator, No.388 Gaoxin 2nd Road,

East Lake High-tech Development Zone,

Wuhan,, Hubei, 430074

China

Phone: +86-027-87384275
+86-027-87800889

Email: sales1@fn-test.com

Company Profile

Website: www.fn-test.com

(1) Elevated serum PAR-1 levels as an emerging biomarker of inflammation to predict the dengue infection severityJournal of medical virologyJanuary 1, 2023Sibia RS, Sood A, Subedi A, Sharma A, Mittal A, Singh G, Singh TG, Jaura RS, Goyal S.

(2) Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patientsInflammopharmacologyOctober 1, 2022Goyal S, Sood A, Gautam I, Pradhan S, Mondal P, Singh G, Jaura RS, Singh TG, Sibia RS.

(3) Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple SclerosisInternational journal of molecular sciencesOctober 19, 2020Dziedzic A, Miller E, Bijak M, Przyslo L, Saluk-Bijak J.

Be the First to Write a Review!